Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-27

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-20

    Virtual Booth

    Contact Supplier

    Menu

    Collagenase Clostridium Histolyticum

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 7Xiaflex

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharma

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2020 Revenue in Millions : 316

    2019 Revenue in Millions : 328

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharma

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2021 Revenue in Millions : 432

    2020 Revenue in Millions : 316

    Growth (%) : 37

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharma

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2022 Revenue in Millions : 439

    2021 Revenue in Millions : 432

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharma

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2023 Revenue in Millions : 475

    2022 Revenue in Millions : 439

    Growth (%) : 8

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharmaceuticals

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Bone and Joint Diseases

    Currency : USD

    2017 Revenue in Millions : 213

    2016 Revenue in Millions : 190

    Growth (%) : 12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharmaceuticals

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Bone And Joint Diseases

    Currency : USD

    2018 Revenue in Millions : 264

    2017 Revenue in Millions : 213

    Growth (%) : 24%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Xiaflex

    Collagenase Clostridium Histolyticum

    arrow
    BIO CEO & Investor
    Not Confirmed

    Brand Name : Xiaflex

    Ireland
    arrow
    BIO CEO & Investor
    Not Confirmed

    Endo Pharma

    Collagenase Clostridium Histolyticum

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2019 Revenue in Millions : 328

    2018 Revenue in Millions : 265

    Growth (%) : 24

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF